UK markets closed

Sartorius Stedim Biotech S.A. (0RG8.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
373.40+5.96 (+1.62%)
At close: 08:40AM BST
Currency in EUR

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.64
52-week change 3-15.51%
S&P500 52-week change 318.96%
52-week high 3399.90
52-week low 3232.50
50-day moving average 3262.38
200-day moving average 3310.17

Share statistics

Avg vol (3-month) 348.15k
Avg vol (10-day) 349.47k
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 828.83M
% held by insiders 169.71%
% held by institutions 113.49%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.69
Trailing annual dividend yield 30.19%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 26:1
Last split date 306 May 2016

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 Jun 2024

Profitability

Profit margin 6.17%
Operating margin (ttm)14.78%

Management effectiveness

Return on assets (ttm)3.93%
Return on equity (ttm)5.31%

Income statement

Revenue (ttm)2.75B
Revenue per share (ttm)29.15
Quarterly revenue growth (yoy)4.50%
Gross profit (ttm)N/A
EBITDA 651.9M
Net income avi to common (ttm)169.5M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)-64.20%

Balance sheet

Total cash (mrq)454.1M
Total cash per share (mrq)4.77
Total debt (mrq)2.92B
Total debt/equity (mrq)74.38%
Current ratio (mrq)1.94
Book value per share (mrq)40.84

Cash flow statement

Operating cash flow (ttm)706.1M
Levered free cash flow (ttm)105.29M